Delivery Order SPE2DB22D2006-SPE2DB25FW1HV
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $47K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Imatinib Mesylate 400 mg tablets in quantities of 30 units at a firm fixed price of $1,252.05. This order, which represents a non-competitive set-aside contract, is due for completion by July 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this delivery through its...
- The Defense Logistics Agency awarded a $62,130 delivery order to Amerisourcebergen Drug Corporation for Imatinib Mesylate 100mg tablets. Under this firm fixed price contract, Amerisourcebergen will provide 90 tablets of the generic cancer drug to an address in Conshohocken, Pennsylvania by June 28, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen frequently receives delivery orders under the DLA's Prime Vendor program to support the medical readiness...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,139,158 units of Imatinib Mesylate 400 mg tablets in 30-count packages, with a ceiling value of $1,179.42. The contract is a firm-fixed-price, non-set-aside contract type with a performance period through May 6, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imatinib Mesylate 100 mg tablets, a medication used to treat certain types of cancer. The contract has a firm fixed price of $1,064.58 and a completion date of May 16, 2025. The contract is not set aside and was awarded on May 15, 2025. Amerisourcebergen Drug Corp holds a...
- The Defense Logistics Agency awarded a $499 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400mg Imatinib Mesylate tablets. As the prime contractor, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania, fulfilling the agency's requirements under the contract which runs from July 25 to July 26, 2023. The Defense Logistics Agency leverages strategic sourcing vehicles to procure pharmaceuticals and medical supplies in support of its...
- The Defense Logistics Agency awarded a $1,194 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400mg Imatinib Mesylate tablets. Under this order, Amerisourcebergen will deliver 30 tablets of the generic cancer drug to an address in Conshohocken, Pennsylvania by June 21, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen likely supports DLA's mission to provide medical supplies and equipment to military treatment facilities...
- This federal contract award, valued at $4,087.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imatinib Mesylate 100 mg tablets, a medication used to treat certain types of cancer. The contract is a Firm Fixed Price Delivery Order with a completion date of January 6, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $4,433.72 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to supply 400mg Imatinib Mesylate tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The contract period of performance spans October 21 to October 22, 2021. No subcontractors or set aside designations were identified. This delivery order was issued against an...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imatinib Mesylate 400 mg tablets, a medication used to treat certain types of cancer. The contract has a ceiling value of $1,871.93 and a completion date of June 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,369.66 with a completion date of November 18, 2024. The contract provides the Defense Logistics Agency (DLA) with 4566447009 - IMATINIB MESYLATE 400 MG TAB 30S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...